Radiation technologies can precisely modify biomaterials, enabling their use in a wide range of advanced health care applications. A new IAEA coordinated research project will explore how these technologies can support the development of innovative biomaterials and medical devices for sustainable health care solutions. (Graphic: IAEA/A. Schlosman)
The IAEA is inviting research organizations to join its new project to accelerate the development of advanced biomaterials for next generation health care solutions. The focus is on the design of multifunctional, smart, high-performance biomaterials, including novel medical devices and responsive material systems, and turning laboratory innovation into practice.
In health care, biomaterials underpin a wide range of applications in medical devices, implants, tissue engineering, diagnostic technologies and more. They play a key role in advancing minimally invasive procedures, personalized medicine and real-time health monitoring.
Recent scientific progress has led to the emergence of multifunctional and smart biomaterials capable of dynamically responding to biological signals. However, translating these laboratory‑scale breakthroughs into clinically viable and scalable applications remains challenging. These challenges include ensuring material stability, achieving reliable sterilization, maintaining consistent biological performance and enabling cost effective manufacturing.
Why Radiation in Health Care Products?
Radiation technologies offer a powerful and underutilized solution to overcome these barriers. Techniques such as gamma radiation, X rays and electron beams can precisely modify biomaterials at the molecular and microstructural levels while simultaneously enabling sterilization. These processes are clean, do not require chemical additives, and are compatible with scalable industrial production.
The five-year Coordinated Research Project (CRP), entitled Biomaterials for Sustainable Health Care Products , is aimed at addressing gaps in the development of integrated biomaterial systems that effectively combine structural performance, biological functionality, and smart capabilities. Bringing together experts from multiple disciplines, including materials science, biomedical engineering and radiation technology, the CRP will focus on broad range of advanced materials and applications, such as:
- Additive manufacturing (3D-printed) scaffolds for tissue engineering and regenerative medicine.
- Smart biomaterials capable of responding to environmental or biological stimuli.
- Biosensors and sensing-enabled medical devices for real-time monitoring and diagnostics.
- Advanced coatings and surface-modified materials to improve biocompatibility and performance of implants and devices.
By leveraging radiation technologies, the CRP aims to enable precise control over material properties such as cross-linking, degradation, mechanical strength and biological interaction, which are critical for these applications.
Bridging Research and Application
The overall objective of the CRP is to advance radiation technologies for the controlled modification and functionalization of biomaterials, supporting their transition from research to practical health care use.
Specifically, the project will:
- Develop advanced biomaterials using radiation engineering techniques to tailor structure and function.
- Design smart biomaterials and medical devices with integrated sensing, signalling and/or responsive capabilities.
- Establish standardised protocols for radiation processing and modification of advanced biomaterials.
- Generate preclinical proof-of-concept data to support translation toward real-world medical applications.
- Strengthen links between research groups and industry, facilitating knowledge transfer and early adoption.
- Build a strong and sustainable international research and innovation network in radiation‑engineered biomaterials.
A key feature of this CRP is its strong emphasis on translation, ensuring that research outputs are closely aligned with clinical needs, regulatory considerations and industrial scalability. The aim is to accelerate the pathway from laboratory innovation to health care impact and support the development of scalable, regulatory-aware and market-relevant solutions, aligned with the priorities and needs of IAEA Member States.
